Symbol
| BTK
| contributors: mct/pgu - updated : 08-06-2017
|
HGNC name
| Bruton agammaglobulinemia tyrosine kinase
|
HGNC id
| 1133
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in chronic lymphocytic leukemia | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| represents a useful marker to identify B cell non-Hodgkin lymphomas | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | hemopathy | | |
promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765 | cardiovascular | atheroma | | |
could be a potent therapeutic target in ischaemic stroke | cancer | hemopathy | | |
is a therapeutic target in acute myeloid leukemia |
| | |